ARTICLE | Company News

Management tracks

July 9, 2016 12:28 AM UTC

Oncology company Lion Biotechnologies Inc. (NASDAQ:LBIO) said CFO Molly Henderson will resign, effective Aug. 16.

Neurology company Ovid Therapeutics Inc. (New York, N.Y.) promoted Yaron Werber to CBO, while remaining CFO, and Dirk Haasner to SVP from VP of global regulatory affairs. ...